Ironwood pharmaceuticals news
WebMar 2, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate Simply Wall St March 2, 2024, 7:09 AM · 6 min read Key Insights The projected fair value... WebJan 29, 2024 · Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults …
Ironwood pharmaceuticals news
Did you know?
WebFeb 13, 2024 · BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … WebApr 13, 2024 · 2024-23 Season Snow: 220.1 inches 2024-22 Season Snow: 182.3 2024-21 Season Snow: 84.4 2024-20 Season Snow: 169.3 2024-19 Season Snow: 182.8
WebApr 15, 2024 · As a group, sell-side analysts forecast that Ironwood Pharmaceuticals, Inc. will post 1.06 earnings per share for the current fiscal year. Insider Transactions at Ironwood Pharmaceuticals. In other news, CEO Thomas A. Mccourt sold 46,129 shares of the business’s stock in a transaction that occurred on Monday, March 27th. The stock was … WebSep 6, 2024 · BOSTON, Mass., September 06, 2024 -- ( BUSINESS WIRE )-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial evaluating LINZESS...
WebApr 12, 2024 · Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)’s beta value is currently sitting at 0.95, while the Average True Range indicator is currently displaying 0.29. With analysts defining $9.00-$16.00 as the low and high price targets, we arrive at a consensus price target of $12.75 for the trailing 12-month period.
WebApr 11, 2024 · Ironwood Pharmaceuticals Inc. on Tuesday said it has eliminated the role of chief operating officer in a streamlining of the healthcare company's executive leadership …
WebApr 6, 2024 · Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. google sheet ifWebDec 16, 2024 · IRONWOOD PHARMACEUTICALS, INC. : News, information and stories for IRONWOOD PHARMACEUTICALS, INC. Nasdaq: IRWD Nasdaq chicken feed torontoWebSep 6, 2024 · BOSTON, Mass., September 06, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial … google sheet google calendarWebApr 11, 2024 · Ironwood Pharmaceuticals - IRWD News Today $10.52 +0.10 (+0.96%) (As of 03/31/2024 06:55 PM ET) Compare Today's Range $10.43 $10.62 50-Day Range $10.37 … google sheet how to add emailWebApr 14, 2024 · In other Ironwood Pharmaceuticals news, CEO Thomas A. Mccourt sold 46,129 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, March … chicken feed tableWeb1 hour ago · The counties faced "severe conditions and sustained serious damage caused by widespread flooding," according to a news release sent by the governor's office Friday. … chicken feed taintedWebApr 11, 2024 · Ironwood Pharmaceuticals Inc. on Tuesday said it has eliminated the role of chief operating officer in a streamlining of the healthcare company's executive leadership team. As a result, the Boston ... google sheet if cell not empty